Biolog-id Overview
- Year Founded
-
2005
- Status
-
Private
- Employees
-
89
- Latest Deal Type
-
Later Stage VC
- Latest Deal Amount
-
$10.9M
- Investors
-
1
Biolog-id General Information
Description
Developer of healthcare management platform designed to offer management and traceability of sensitive health products. The company's platform includes developing and implementing alternatives that digitally transform routine processes into actionable data supporting operational and strategic decisions for sensitive therapeutic products such as blood products, chemotherapies and parenteral nutrition, enabling clients to have traceability and other information on its products.
Contact Information
Website
www.biolog-id.comCorporate Office
- 1 Rue du Commandant Robert Malrait
- ZA des Granges
- 27300 Bernay
- France
Corporate Office
- 1 Rue du Commandant Robert Malrait
- ZA des Granges
- 27300 Bernay
- France
Biolog-id Timeline
Biolog-id Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Later Stage VC | 02-Mar-2023 | $10.9M | Completed | Generating Revenue | ||
| 8. Reverse Merger | 23-Aug-2022 | Cancelled | Generating Revenue | |||
| 7. Later Stage VC | 05-May-2022 | Completed | Generating Revenue | |||
| 6. Later Stage VC | 12-Sep-2020 | Completed | Generating Revenue | |||
| 5. Later Stage VC | 19-Nov-2019 | Completed | Generating Revenue | |||
| 4. Later Stage VC | 08-Nov-2016 | Completed | Generating Revenue | |||
| 3. Later Stage VC | 30-Apr-2015 | Completed | Generating Revenue | |||
| 2. Later Stage VC | 01-May-2011 | Completed | Generating Revenue | |||
| 1. Later Stage VC | 01-Jan-2010 | Completed | Generating Revenue |
Biolog-id Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| ABBSA 2015 | ||||||||
| ABBSA 2015 | ||||||||
| ABBSA 2015 | ||||||||
| Ordinary | 1,212,450 | $1.070679 | $26.49 | $26.49 | 1x | $26.49 | 14.45% | |
| Ordinary | 690,029 | $1.070679 | $10.86 | $10.86 | 1x | $10.86 | 8.22% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
Biolog-id Comparisons
Industry
Financing
Details
Biolog-id Competitors (1)
One of Biolog-id’s competitors is Haemonetics, a Formerly PE-Backed company based in Boston, MA.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Haemonetics | Formerly PE-Backed | Boston, MA |
Biolog-id Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Biolog-id Patents
Biolog-id Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| FR-3122288-A1 | Wireless communication device comprising a plurality of antennas, associated installation and communication method | Active | 27-Apr-2021 | ||
| AU-2022267004-A1 | Wireless communication device comprising a plurality of antennas, associated facility and communication method | Pending | 27-Apr-2021 | ||
| CA-3216949-A1 | Wireless communication device comprising a plurality of antennas, associated facility and communication method | Pending | 27-Apr-2021 | ||
| US-20240213676-A1 | Wireless communication device comprising a plurality of antennas, associated facility and communication method | Pending | 27-Apr-2021 | ||
| EP-4330852-A1 | Wireless communication device comprising a plurality of antennas, associated facility and communication method | Pending | 27-Apr-2021 | H01Q7/00 |
Biolog-id Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Biolog-id Investors (1)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Xerys Invest | PE/Buyout | Minority |
Biolog-id Investments (1)
Biolog-id’s most recent deal was a Buyout/LBO with Veridentia. The deal was made on 01-Jun-2018.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Veridentia | 01-Jun-2018 | Buyout/LBO | Other Devices and Supplies |
Biolog-id FAQs
-
When was Biolog-id founded?
Biolog-id was founded in 2005.
-
Where is Biolog-id headquartered?
Biolog-id is headquartered in Bernay, France.
-
What is the size of Biolog-id?
Biolog-id has 89 total employees.
-
What industry is Biolog-id in?
Biolog-id’s primary industry is Other Healthcare Technology Systems.
-
Is Biolog-id a private or public company?
Biolog-id is a Private company.
-
What is the current valuation of Biolog-id?
The current valuation of Biolog-id is .
-
What is Biolog-id’s current revenue?
The current revenue for Biolog-id is .
-
How much funding has Biolog-id raised over time?
Biolog-id has raised $86.9M.
-
Who are Biolog-id’s investors?
Xerys Invest has invested in Biolog-id.
-
Who are Biolog-id’s competitors?
Haemonetics is a competitor of Biolog-id.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
